SP600125 enhances the anti-apoptotic capacity and migration of bone marrow mesenchymal stem cells treated with tumor necrosis factor-α.
Wei, Bo
SP600125 enhances the anti-apoptotic capacity and migration of bone marrow mesenchymal stem cells treated with tumor necrosis factor-α. [electronic resource] - Biochemical and biophysical research communications 07 2016 - 301-7 p. digital
Publication Type: Journal Article
1090-2104
10.1016/j.bbrc.2016.05.107 doi
Animals
Anthracenes--pharmacology
Apoptosis--drug effects
Arthritis, Rheumatoid--drug therapy
Cell Movement--drug effects
Cell Survival--drug effects
Cells, Cultured
JNK Mitogen-Activated Protein Kinases--antagonists & inhibitors
Mesenchymal Stem Cells--drug effects
Osteoarthritis--drug therapy
Protein Kinase Inhibitors--pharmacology
Rats, Sprague-Dawley
Tumor Necrosis Factor-alpha--immunology
SP600125 enhances the anti-apoptotic capacity and migration of bone marrow mesenchymal stem cells treated with tumor necrosis factor-α. [electronic resource] - Biochemical and biophysical research communications 07 2016 - 301-7 p. digital
Publication Type: Journal Article
1090-2104
10.1016/j.bbrc.2016.05.107 doi
Animals
Anthracenes--pharmacology
Apoptosis--drug effects
Arthritis, Rheumatoid--drug therapy
Cell Movement--drug effects
Cell Survival--drug effects
Cells, Cultured
JNK Mitogen-Activated Protein Kinases--antagonists & inhibitors
Mesenchymal Stem Cells--drug effects
Osteoarthritis--drug therapy
Protein Kinase Inhibitors--pharmacology
Rats, Sprague-Dawley
Tumor Necrosis Factor-alpha--immunology